Inhalation Sciences receives new order worth 62 000 EURO from University of Vienna
(Stockholm, 16 September 2022) Inhalation Sciences AB (ISAB) has received a new order from prestigious returning client the Department of Pharmaceutical Technology and Biopharmaceutics at the University of Vienna for the advanced in vitro cell exposure module XposeALI[®].The client previously purchased ISAB’s aerosol generation platform PreciseInhale[®], in November 2020, plus two in vivo exposure modules. PreciseInhale[®] and its suite of advanced exposure modules can generate voluminous high-precision data through all phases of preclinical research, from in vitro to in vivo, from even